Brandle et al v. McKesson Corporation et al

Filing 25

ORDER REQUESTING ADDITIONAL BRIEFING: All defendants are to file one joint brief no more than ten pages by noon on 3/25/2013. All plaintifs to file one joint brief no more than ten pages by noon on 3/25/2013. Signed by Judge William Alsup on 3/19/2013. (whasec, COURT STAFF) (Filed on 3/19/2013)

Download PDF
1 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE NORTHERN DISTRICT OF CALIFORNIA 8 9 11 For the Northern District of California United States District Court 10 JAMES BRINDLE, REBECCA GREGG, and DIANA GUTHRIE, No. C 12-05970 WHA Plaintiffs, 12 13 14 15 v. ORDER REQUESTING ADDITIONAL BRIEFING MCKESSON CORPORATION, et al., Defendants. / 16 17 In this pharmaceutical product liability action, plaintiffs move to remand back to state 18 court. Defendants oppose on federal question and supplemental jurisdiction grounds. In PLIVA, 19 Inc. v. Mensing, 131 S.Ct. 2567 (2011), the Supreme Court held that state failure-to-warn claims 20 are preempted by federal law. While “it is now settled law that a case may not be removed to 21 federal court on the basis of a federal defense, including the defense of pre-emption,” 22 Caterpillar Inc. v. Williams, 482 U.S. 386, 393 (1987) (citations omitted) (emphasis in original), 23 there is an “independent corollary.” See id. (citations omitted). “On occasion, the Court has 24 concluded that the pre-emptive force of a statute is so ‘extraordinary’ that it ‘converts an 25 ordinary state common-law complaint into one stating a federal claim for purposes of the well- 26 pleaded complaint rule.’” Id. (quoting Metropolitan Life Ins. Co. v. Taylor, 481 U.S. 58, 65 27 (1987)). Then, “[o]nce an area of state law has been completely pre-empted, any claim 28 purportedly based on that pre-empted state law is considered, from its inception, a federal claim, 1 and therefore arises under federal law.” Id. (quoting Franchise Tax Bd. of State of Cal. v. 2 Constr. Laborers Vacation Trust for S. Cal, 463 U.S. 1, 24 (1983)). 3 4 5 6 This order requests additional briefing on this issue. Specifically, the parties must address the following three questions: First, after Mensing, are plaintiffs’ state failure-to-warn claims here “completely pre-empted” such that federal-question jurisdiction is proper? 7 Second, in the event that federal question jurisdiction is proper, has Congress explicitly 8 authorized a private right of action regarding the labeling of manufacturers of generic drugs or 9 alternatively, has one been implied by law? Third, what effect (if any) will the Supreme Court’s decision in Mutual Pharm. Co., 11 For the Northern District of California United States District Court 10 Inc. v. Bartlett, 133 S.Ct. 694 (2012), granting cert. to Bartlett v. Mutual Pharm. Co., Inc., 12 678 F.3d 30 (1st Cir. 2012), have on this action? 13 All defendants are to file one joint brief of no more than ten pages by NOON ON 14 MARCH 25, 2013. All plaintiffs are to file one joint brief of no more than ten pages by NOON 15 ON MARCH 25, 2013. 16 17 IT IS SO ORDERED. 18 19 Dated: March 19, 2013. WILLIAM ALSUP UNITED STATES DISTRICT JUDGE 20 21 22 23 24 25 26 27 28 2

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?